Rights
IP position
Ownership, protection, freedom to operate, and time remaining on the patent clock.
For universities and technology transfer offices
Turn research assets into companies that can carry them.
AVIVA helps institutions decide which discoveries have a credible company path, then builds the operating foundation required to advance them. The initial readiness screen is free to the institution.
The institutional challenge
Patentability and company readiness answer different questions.
A TTO can protect and license an invention while major operating gaps remain unresolved. Those gaps affect formation, financing, development, and the ability to recruit a capable team. Fewer than one in three university patents are ever licensed, and institutions capture only about 16 percent of the economic value their patented research generates.
The gap we fill
AVIVA works alongside the technology transfer function.
The institution decides what to protect and license. AVIVA evaluates commercialization readiness and, when the evidence supports it, builds the operating company around the asset.
Institutional role
Protect and transfer
- Invention disclosure
- Patent strategy
- Licensing structure
- Institutional approvals
AVIVA role
Measure and build
- Spinout readiness
- Company architecture
- Operating leadership
- Capital preparation
Spinout Readiness
A free, standardized screen before scarce resources are committed.
AVIVA Score™ gives TTO leaders a consistent, no-cost way to identify which disclosures merit deeper company-building work. AVIVA refers to this internal assessment as CRI-1.
Evidence
Translational case
Proof, reproducibility, development assumptions, and the next evidence milestone.
Execution
Development path
Regulatory route, manufacturing feasibility, timing, and material operating dependencies.
Company
Formation case
Leadership needs, capital requirement, business model, and a credible reason to form now.
Engagement path
From disclosure review to operating company.
The scope follows the asset. AVIVA can stop at a clear readiness decision or continue into formation and execution.
Screen
Review the asset for spinout readiness and identify the material gaps.
Decide
Define whether to advance, pause, license, or prepare for formation.
Form
Set the entity, leadership, capital plan, and development foundation.
Advance
Build through the milestones that make the company financeable.
Institutional value
A stronger decision before formation. A stronger company after it.
AVIVA gives the institution a documented readiness view, a practical operating agenda, and an experienced team capable of taking responsibility for the work. Where a spinout goes forward, AVIVA participates as an equity partner in the company it helps build, so its economics depend on the company succeeding rather than on fees for advice.